ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 261 out of 670

$443K Total Retail Price of All Prescriptions

Rank: 229 out of 670

385 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 356 344 1 5
SYNTHROID 324 291 2 47
SIMVASTATIN 316 304 3 4
AMLODIPINE BESYLATE 247 237 4 7
LISINOPRIL 207 174 5 3
METFORMIN HCL ER 190 157 6 63
PANTOPRAZOLE SODIUM 183 170 7 41
ZOLPIDEM TARTRATE 174 160 8 23
GLIMEPIRIDE 154 144 9 32
SERTRALINE HCL 145 133 10 22
CITALOPRAM HBR 143 132 11 20
HYDROCHLOROTHIAZIDE 131 113 12 10
NEXIUM 124 100 13 14
FLUTICASONE PROPIONATE 119 115 14 37
CEFUROXIME 113 108 15 121
TRAMADOL HCL 111 111 16 21
CRESTOR 109 83 17 18
LOSARTAN-HYDROCHLOROTHIAZIDE 102 98 18 73
METOPROLOL SUCCINATE 100 100 19 12
ACETAMINOPHEN-CODEINE 95 95 S3 20 119
MELOXICAM 93 79 21 33
CYMBALTA 85 71 22 36
LEVOFLOXACIN 77 70 23 88
ATORVASTATIN CALCIUM 75 73 24 15
ALENDRONATE SODIUM 73 73 25 43
CLOPIDOGREL 73 73 25 24
GABAPENTIN 70 66 27 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 70 27 27
LOSARTAN POTASSIUM 67 67 29 26
ALLOPURINOL 66 62 30 38
LOVAZA 61 54 31 108
PRAVASTATIN SODIUM 60 60 32 19
LEVOTHYROXINE SODIUM 59 52 33 2
METOPROLOL TARTRATE 59 59 33 9
LANSOPRAZOLE 58 54 35 86
PLAVIX 56 56 36 34
POTASSIUM CHLORIDE 53 52 37 16
PROAIR HFA 51 50 38 28
CLONIDINE HCL 50 50 39 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.